NCT06156514View on ClinicalTrials.gov

Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 6, 2019

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2029

Conditions
Locally Advanced Cervical CancerGemcitabineChemo-radiotherapy
Interventions
DRUG

Gemcitabine

Weekly application of gemcitanibe at 300 mg/m2 intravenously in a 30-minute infusion, concomitantly with radiotherapy for a total of 5-6 weeks followed by bachytherapy, in patients diagnosed with locally advanced cervical cancer

DRUG

Cisplatin

Weekly application of Cisplatin at 40 mg/m2 intravenously in a 60-minute infusion, concomitantly with radiotherapy for a total of 5-6 weeks followed by bachytherapy, in patients diagnosed with locally advanced cervical cancer

Trial Locations (1)

14080

RECRUITING

National Cancer Institute of Mexico, Mexico City

All Listed Sponsors
lead

National Institute of Cancerología

OTHER_GOV